Key Figures

Key Figures for the First Half of 2016

In millions of € unless otherwise specified
  Group Bioprocess Solutions Lab Products & Services
  6-mo. 2016 6-mo. 2015 Δ in % reported 6-mo. 2016 6-mo. 2015 Δ in % reported 6-mo. 2016 6-mo. 2015 Δ in % reported
Sales Revenue and Order Intake       
Sales revenue 625.4 535.3 16.8 469.8 384.9 22.1 155.7 150.5 3.5
Order intake 677.6 577.8 17.3 519.2 427.9 21.4 158.4 149.9 5.7
Results        
EBITDA1 153.4 121.1 26.6 128.1 97.8 31.0 25.3 23.4 8.4
EBITDA margin1 in % 24.5 22.6   27.3 25.4   16.3 15.5  
Net result2 62.4 47.8 30.4            
Financial Data per Share
Earnings per ord. share2 in € 0.91 0.703 29.6            
Earnings per pref. share2 in € 0.92 0.713 30.1            
30.06.201631.12.2015
Balance Sheet | Financials
Balance sheet total1,673.81,437.2
Equity654.2644.8
Equity ratio in %39.144.9
Net debt483.9344.0
Net debt | underlying EBITDA1.61.3

Key Figures for the Second Quarter of 2016

In millions of € unless otherwise specified

Group Bioprocess Solutions Lab Products & Services
  Q2
2016
Q2
2015
Δ in %
reported
Q2
2016
Q2
2015
Δ in %
reported
Q2
2016
Q2
2015
Δ in %
reported
Sales Revenue and Order Intake         
Sales revenue 323.5 277.3 16.7 242.8 198.9 22.1 80.7 78.4 3.0
Order intake 347.5 301.7 15.2 265.0 223.2 18.7 82.5 78.4 5.1
Results        
EBITDA1 81.1 63.6 27.4 67.1 51.2 31.0 14.0 12.4 12.6
EBITDA margin1 in % 25.1 23.0   27.6 25.8   17.3 15.8  
Net result2 33.1 25.7 28.9            
Financial Data per Share
Earnings per ord. share2 in € 0.48 0.383 28.4            
Earnings per pref. share2 in € 0.48 0.383 28.4            

1 Excluding extraordinary items

2 After non-controlling interest, adjusted for extraordinary items as well as non-cash amortization, and based on the normalized financial result as well as the corresponding tax effects for each of these items; for H1 2015 continued operations.

3 Adjusted for stock split; rounded values

4 Figures are not audited nor reviewed